Analyst Erin Wright of Morgan Stanley maintained a Buy rating on UnitedHealth (UNH – Research Report), retaining the price target of ...

Mairs & Power, an investment advisor, released the “Mairs & Power Growth Fund” third quarter 2024 investor letter. A copy of ...

UnitedHealth Group (UNH) closed at $606.79 in the latest trading session, marking a +0.16% move from the prior day. This change lagged the S&P 500's 0.57% gain on the day. On the other hand, the Dow ...

Change Healthcare—a subsidiary of the global health company UnitedHealth Group — has restored its medical billing services ...

A conservative federal judge in Texas has ruled in favor of UnitedHealth Group over Medicare Advantage star ratings.

UnitedHealth Group is a top dividend growth stock with strong financials and potential for 20%+ returns by 2026. Read more ...

The U.S. Department of Justice and four state attorney generals filed an antitrust lawsuit against UnitedHealth Group on ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.23% of ...

Judge Jeremy Kernodle, of the U.S. District Court for the Eastern District of Texas, ruled CMS violated the Administrative ...

United used an algorithm system to identify patients who it determined were getting too much therapy and then limited ...

UnitedHealth Group will host its annual Investor Conference for analysts and institutional investors in New York City on Wednesday, December 4, 2024, beginning at 8:00 a.m. EST.

UnitedHealth Group (UNH) stock surged more than 3% on Wednesday as investors bid up most US health insurers after ...